Active site-directed antibodies identify calpain II as an early-appearing and pervasive component of neurofibrillary pathology in Alzheimer's disease

被引:123
作者
Grynspan, F
Griffin, WR
Cataldo, A
Katayama, S
Nixon, RA
机构
[1] MCLEAN HOSP, MAILMAN RES CTR, LABS MOL NEUROSCI, BELMONT, MA 02178 USA
[2] HARVARD UNIV, SCH MED, DEPT PSYCHIAT, BELMONT, MA 02178 USA
[3] HARVARD UNIV, SCH MED, PROGRAM NEUROSCI, BELMONT, MA 02178 USA
[4] MITSUBISHI CHEM CORP, YOKOHAMA, KANAGAWA 227, JAPAN
关键词
calcium activated neutral proteinase; Alzheimer's disease; neurofibrillary tangle; calcium; calpain antibody; cytoskeleton;
D O I
10.1016/S0006-8993(97)00384-3
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Calpain proteases influence intracellular signaling pathways and regulate cytoskeleton organization, but the neuronal and pathological roles of individual isoenzymes are unknown. In Alzheimer's disease (AD), the activated form of calpain I is significantly increased while the fate of calpain II has been more difficult to address. Here, calpain II antibodies raised to different sequences within a cryptic region around the active site, which becomes exposed during protease activation, were shown immunohistochemically to bind extensively to neurofibrillary tangles (NFT), neuritic plaques, and neuropil threads in brains from individuals with AD. Additional 'pre-tangle' granular structures in neurons were also intensely immunostained, indicating calpain II mobilization at very early stages of NFT formation. Total levels of calpain II remained constant in the prefrontal cortex of AD patients but were increased 8-fold in purified NFT relative to levels of calpain I. These results implicate activated calpain II in neurofibrillary degeneration, provide further evidence for the involvement of the calpain system in AD pathogenesis, and imply that neuronal calcium homeostasis is altered in AD. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:145 / 158
页数:14
相关论文
共 109 条